A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients

NCT03037957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 704

Last updated 2017-07-07

No results posted yet for this study

Summary

A multi-center evaluation to assess the diagnostic sensitivity and specificity of the ARIES Group A Strep Assay will be established through a method comparison using prospectively collected, de-identified, clinical samples collected during the enrollment period.

Conditions

  • Pharyngitis Bacterial

Interventions

DEVICE

ARIES Group A Strep Assay

Sponsors & Collaborators

  • Luminex Corporation

    lead INDUSTRY

Principal Investigators

  • Ronald Dunn · Luminex Corporation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-09
Primary Completion
2017-06-02
Completion
2017-06-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03037957 on ClinicalTrials.gov